The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

Lignende værker

• Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
  af: Roerecke, Michael, et al.
  Udgivet: (2015)
• Modelling the consequences of a reduction in alcohol consumption among patients with alcohol dependence based on real-life observational data
  af: Rahhali, Nora, et al.
  Udgivet: (2015)
• The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients
  af: François, Clément, et al.
  Udgivet: (2015)
• Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial
  af: Miyata, Hisatsugu, et al.
  Udgivet: (2019)
• Response to ‘Nalmefene in alcohol‐dependent patients with a high drinking risk: A limited efficacy in reducing alcohol consumption’
  af: Higuchi, Susumu, et al.
  Udgivet: (2020)